New Advances in Research on Alzheimer’s Disease: 2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1135
Special Issue Editors
Interests: coding and non coding RNA; gene expression; neurodegenerative diseases; genetic
Special Issues, Collections and Topics in MDPI journals
Interests: biomedical spectroscopy; clinical spectroscopy; Alzheimer’s disease; breast cancer; nanomedicine; Raman spectroscopy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Alzheimer’s disease (AD) is considered the most common cause of dementia and is an incurable, progressive neurodegenerative disorder. To date, novel disease-modifying therapies have been shown to provide significant benefits to patients who suffer from this devastating disorder.
Moreover, preventive approaches of this pathology that are based on genetic predisposition, senolytic approaches, diet, or intellectual activity are increasingly relevant.
The aim of this Special Issue is to provide (but is not limited to) an overview of the recent advances in the field of novel therapy and targets for Alzheimer’s disease. In addition, data about preventive approaches are welcomed.
We invite researchers to submit original papers and reviews about the discovery of new targets and novel therapies for Alzheimer’s disease. Papers about other types of dementia will also be accepted.
Dr. Stella Gagliardi
Dr. Carlo Morasso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapy
- prevention
- new molecules
- Alzheimer’s disease
- genetics
- nanoformulation
- targets
- dementia
- biomarker discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
